Declining risk of heart failure hospitalization following first acute myocardial infarction in Scotland between 1991-2016

被引:12
作者
Docherty, Kieran F. [1 ]
Jackson, Alice M. [1 ]
Macartney, Mark [2 ]
Campbell, Ross T. [1 ]
Petrie, Mark C. [1 ]
Pfeffer, Marc A. [3 ]
McMurray, John J. V. [1 ]
Jhund, Pardeep S. [1 ,4 ]
机构
[1] Univ Glasgow, BHF Cardiovasc Res Ctr, Glasgow City, Scotland
[2] Publ Hlth Scotland, Edinburgh, Scotland
[3] Harvard Med Sch, Brigham & Womens Hosp, Cardiovasc Div, Boston, MA USA
[4] Univ Glasgow, Glasgow Cardiovasc Res Ctr, Sch Cardiovasc & Metab Hlth, BHF, Glasgow G12 8TA, Scotland
关键词
Heart failure; Myocardial infarction; Epidemiology; LEFT-VENTRICULAR DYSFUNCTION; ST-SEGMENT ELEVATION; TEMPORAL TRENDS; RANDOMIZED-TRIALS; SEX-DIFFERENCES; PREDICTORS; MORTALITY; OUTCOMES; DISEASE; IMPACT;
D O I
10.1002/ejhf.2965
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim Mortality from acute myocardial infarction (AMI) has declined, increasing the pool of survivors at risk of later development of heart failure (HF). However, coronary reperfusion limits infarct size and secondary prevention therapies have improved. In light of these competing influences, we examined long-term trends in the risk of HF hospitalization (HFH) following a first AMI occurring in Scotland over 25 years. Methods and results All patients in Scotland discharged alive after a first AMI between 1991 and 2015 were followed until a first HFH or death until the end of 2016 (minimum follow-up 1 year, maximum 26 years). A total of 175 672 people with no prior history of HF were discharged alive after a first AMI during the period of study. A total of 21 445 (12.2%) patients had a first HFH during a median follow-up of 6.7 years. Incidence of HFH (per 1000 person-years) at 1 year following discharge from a first AMI decreased from 59.3 (95% confidence interval [CI] 54.2-64.7) in 1991 to 31.3 (95% CI 27.3-35.8) in 2015, with consistent trends seen for HF occurring within 5 and 10 years. Accounting for the competing risk of death, the adjusted risk of HFH at 1 year after discharge decreased by 53% (95% CI 45-60%), with similar decreases at 5 and 10 years. Conclusion The incidence of HFH following AMI in Scotland has decreased since 1991. These trends suggest that better treatment of AMI and secondary prevention are having an impact on the risk of HF at a population level. [GRAPHICS] .
引用
收藏
页码:1213 / 1224
页数:12
相关论文
共 64 条
  • [1] [Anonymous], 1995, J Clin Epidemiol, V48, P1441, DOI [10.1016/0895-4356(95)00530-7, DOI 10.1016/0895-4356(95)00530-7]
  • [2] Evidence-based medication and revascularization:: powerful tools in the management of patients with diabetes and coronary artery disease:: a report from the Euro Heart Survey on diabetes and the heart
    Anselmino, Matteo
    Malmberg, Klas
    Ohrivik, John
    Ryden, Lars
    [J]. EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION, 2008, 15 (02): : 216 - 223
  • [3] Left ventricular function and heart failure in myocardial infarction: Impact of the new definition in the community
    Arruda-Olson, Adelaide M.
    Pellikka, Patricia A.
    Bursi, Francesca
    Jaffe, Allan S.
    Santrach, Paula J.
    Kors, Jan A.
    Killian, Jill M.
    Weston, Susan A.
    Roger, Veronique L.
    [J]. AMERICAN HEART JOURNAL, 2008, 156 (05) : 810 - 815
  • [4] Temporal Trends in Utilization of Cardiac Therapies and Outcomes for Myocardial Infarction by Degree of Chronic Kidney Disease: A Report From the NCDR Chest Pain MI Registry
    Bagai, Akshay
    Lu, Di
    Lucas, Joseph
    Goyal, Abhinav
    Herzog, Charles A.
    Wang, Tracy Y.
    Goodman, Shaun G.
    Roe, Matthew T.
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2018, 7 (24):
  • [5] Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins
    Baigent, C
    Keech, A
    Kearney, PM
    Blackwell, L
    Buck, G
    Pollicino, C
    Kirby, A
    Sourjina, T
    Peto, R
    Collins, R
    Simes, J
    [J]. LANCET, 2005, 366 (9493) : 1267 - 1278
  • [6] Sacubitril/valsartan versus ramipril for patients with acute myocardial infarction: win-ratio analysis of the PARADISE-MI trial
    Berwanger, Otavio
    Pfeffer, Marc
    Claggett, Brian
    Jering, Karola S.
    Maggioni, Aldo P.
    Steg, Philippe Gabriel
    Mehran, Roxana
    Lewis, Eldrin F.
    Zhou, Yinong
    van der Meer, Peter
    De Pasquale, Carmine
    Merkely, Bela
    Filippatos, Gerasimos
    McMurray, John J., V
    Granger, Christopher B.
    Solomon, Scott D.
    Braunwald, Eugene
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 (10) : 1918 - 1927
  • [7] Bottle A, 2018, HEART, V104, P600, DOI [10.1136/heartjnl-2017-312183, 10.1136/heartjnl-2017-312930]
  • [8] Editor's Choice-Sex differences in young patients with acute myocardial infarction: A VIRGO study analysis
    Bucholz, Emily M.
    Strait, Kelly M.
    Dreyer, Rachel P.
    Lindau, Stacy T.
    D'Onofrio, Gail
    Geda, Mary
    Spatz, Erica S.
    Beltrame, John F.
    Lichtman, Judith H.
    Lorenze, Nancy P.
    Bueno, Hector
    Krumholz, Harlan M.
    [J]. EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE, 2017, 6 (07) : 610 - 622
  • [9] National Trends in Heart Failure Hospitalization After Acute Myocardial Infarction for Medicare Beneficiaries 1998-2010
    Chen, Jersey
    Hsieh, Angela Fu-Chi
    Dharmarajan, Kumar
    Masoudi, Frederick A.
    Krumholz, Harlan M.
    [J]. CIRCULATION, 2013, 128 (24) : 2577 - 2584
  • [10] Temporal trends and patterns in heart failure incidence: a population-based study of 4 million individuals
    Conrad, Nathalie
    Judge, Andrew
    Tran, Jenny
    Mohseni, Hamid
    Hedgecott, Deborah
    Crespillo, Abel Perez
    Allison, Moira
    Hemingway, Harry
    Cleland, John G.
    McMurray, John J. V.
    Rahimi, Kazem
    [J]. LANCET, 2018, 391 (10120) : 572 - 580